ArticleComputational and structural biotechnology journal2025
The impact of dropouts in scRNAseq dense neighborhood analysis.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Benchmarking cell-type-specific spatially variable gene detection methods.Briefings in bioinformatics · 2026Article
- Pathway Analysis Interpretation in the Multi-Omic Era.Biotech (Basel (Switzerland)) · 2025Review
- GSNCASCR: An R Package to Identify Differentially Co-Expressed Curated Gene Sets with Single-Cell RNA-Seq Data.International journal of molecular sciences · 2025Article
- Comparing gene-gene co-expression network approaches for the analysis of cell differentiation and specification on scRNAseq data.Computational and structural biotechnology journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single cell RNA sequencing (scRNAseq) provides the possibility to investigate transcriptomic profiles on a single cell level. However, the data show unique challenges in comparison to bulk transcriptomic data, one being high dropout rates, which yields high sparsity data. Many classical analysis and preprocessing pipelines are based on the assumption that poor data can be counteracted by quantity and that similar cells (samples) are close to each other in space. Clustering is commonly used to detect clusters (dense local cell neighborhoods) under the assumption that similar cells are close to each other in space (where close is dependent on the (distance) metric used). The most commonly used clustering methodologies to detect dense local neighborhoods are based on graph clustering on a nearest neighbor graph. However, high dropout rates may break this assumption and make it difficult to reliably detect such dense local neighborhoods. We assess the cluster homogeneity and stability under increasing degrees of dropouts in one of the most popular clustering pipelines (dimensionality reduction + graph based clustering), as provided by scRNAseq analyses packages Seurat and Scanpy. Our study showcases that while the default pipeline performs well in terms of cluster homogeneity (i.e., cells in a cluster are of the same type), also with increasing dropout rates, the stability of clusters (i.e., cell pairs consistently being in the same cluster) decreases. This implies that sub-populations within cell types are increasingly difficult to identify under increasing dropout rates because observations are not consistently close. Our results challenge the current practice of using default clustering pipelines and the general assumption of identifiable local neighborhoods on high dropout data. Hence, these results suggest that careful consideration in interpretation and downstream analysis need to be made when relying on local neighborhoods and clusters on scRNAseq data. In addition, these results call for extensive benchmarking, to identify and provide methods robust in their local neighborhood relationships on data containing low to high dropout rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.